npj Parkinson's Disease (May 2022)

Neuropathology of Parkinson’s disease after focused ultrasound thalamotomy

  • Shunsuke Koga,
  • Mariam Ishaque,
  • W. Jeffrey Elias,
  • Binit B. Shah,
  • Aya Murakami,
  • Dennis W. Dickson

DOI
https://doi.org/10.1038/s41531-022-00319-6
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Focused ultrasound (FUS) thalamotomy is an emerging treatment for tremor-dominant Parkinson’s disease (PD). We report the first postmortem neuropathologic study of FUS thalamotomy in a 68-year-old man with tremor-dominant PD, which was performed seven months before he died. Although the peak voxel temperature at the target was <54 °C, his tremor improved on intraoperative and postoperative assessments. Additionally, postoperative MRI demonstrated a thalamic lesion. Lewy body-related pathology consistent with PD was detected. There was also a 5-mm lesion in the ventral lateral thalamus characterized by demyelination and neuropil loss, with many lipid-laden macrophages, but no lymphocytic infiltrates and relatively preserved neurons and axons. Additional pathological assessments after FUS thalamotomy are needed to determine if the observed brain changes are typical of this procedure.